SPEMACO Pharmaceutical plant announced today on tadawul establishing Dammam Pharmaceutical Company to construct a pharmaceutical products’ factory.
SPIMACO will have 80% interest in the new company, the rest to be owned by ARAC (SPIMACO affiliated co.).
The SAR 120m project is to be financed by the company’s internal resources as well as local banks and SIDF; Construction work is scheduled to be finished by the end of 2014.
Argaam Investment Company has updated the Privacy Policy of its services and digital platforms. Know more about our Privacy Policy here.
Argaam uses cookies to personalize content, to provide social media features and analyze traffic, that we might also share with third parties. You consent to our cookies if you use this website
Comments {{getCommentCount()}}
Be the first to comment
رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}
{{comment.DisplayName}}
{{comment.ElapsedTime}}